$4.75
0.21[4.63%]
At close: Apr 29
$4.75
0[0.00%]
After Hours: 7:21PM EDT
Tenaya Therapeutics
(NASDAQ:TNYA)Tenaya Therapeutics Stock (NASDAQ:TNYA), Analyst Ratings, Price Targets, Predictions
Tenaya Therapeutics Inc has a consensus price target of $16.71, established from looking at the 23 latest analyst ratings. The last 3 analyst ratings were released from Chardan Capital, Canaccord Genuity, and HC Wainwright & Co. on March 21, 2024, March 20, 2024, and March 19, 2024. With an average price target of $18.67 between Chardan Capital, Canaccord Genuity, and HC Wainwright & Co., there's an implied 292.98% upside for Tenaya Therapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Chardan Capital
Canaccord Genuity
HC Wainwright & Co.
Leerink Partners
Morgan Stanley
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Tenaya Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/21/2024 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 321.05% | Chardan Capital | Geulah Livshits | → $20 | Reiterates | Buy → Buy | Get Alert |
| 03/20/2024 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 278.95% | Canaccord Genuity | Whitney Ijem | $19 → $18 | Maintains | Buy | Get Alert |
| 03/19/2024 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 278.95% | HC Wainwright & Co. | Joseph Pantginis | → $18 | Reiterates | Buy → Buy | Get Alert |
| 11/30/2023 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 47.37% | Leerink Partners | Mani Foroohar | → $7 | Initiates | → Outperform | Get Alert |
| 10/09/2023 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 278.95% | HC Wainwright & Co. | Joseph Pantginis | → $18 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2023 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 384.21% | Chardan Capital | Geulah Livshits | → $23 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 257.89% | Canaccord Genuity | Whitney Ijem | $18 → $17 | Maintains | Buy | Get Alert |
| 08/10/2023 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 194.74% | Morgan Stanley | Matthew Harrison | $13 → $14 | Maintains | Overweight | Get Alert |
| 08/10/2023 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 278.95% | HC Wainwright & Co. | Joseph Pantginis | → $18 | Reiterates | Buy → Buy | Get Alert |
| 05/12/2023 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 384.21% | Chardan Capital | Geulah Livshits | $24 → $23 | Maintains | Buy | Get Alert |
| 05/11/2023 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 278.95% | HC Wainwright & Co. | Joseph Pantginis | → $18 | Reiterates | Buy → Buy | Get Alert |
| 03/09/2023 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 405.26% | Chardan Capital | Geulah Livshits | $28 → $24 | Maintains | Buy | Get Alert |
| 03/09/2023 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 278.95% | HC Wainwright & Co. | Joseph Pantginis | $25 → $18 | Maintains | Buy | Get Alert |
| 01/24/2023 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 173.68% | Morgan Stanley | Matthew Harrison | $15 → $13 | Maintains | Overweight | Get Alert |
| 11/11/2022 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 489.47% | Chardan Capital | Geulah Livshits | $30 → $28 | Maintains | Buy | Get Alert |
| 11/08/2022 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 342.11% | Canaccord Genuity | Whitney Ijem | → $21 | Initiates | → Buy | Get Alert |
| 08/11/2022 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 531.58% | Chardan Capital | Geulah Livshits | $31 → $30 | Maintains | Buy | Get Alert |
| 06/15/2022 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 426.32% | HC Wainwright & Co. | Joseph Pantginis | → $25 | Initiates | → Buy | Get Alert |
| 05/17/2022 | TNYA | Buy Now | Tenaya Therapeutics | $4.75 | 215.79% | Morgan Stanley | Matthew Harrison | $19 → $15 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for Tenaya Therapeutics (TNYA)?
The latest price target for Tenaya Therapeutics (NASDAQ: TNYA) was reported by Chardan Capital on March 21, 2024. The analyst firm set a price target for $20.00 expecting TNYA to rise to within 12 months (a possible 321.05% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tenaya Therapeutics (TNYA)?
The latest analyst rating for Tenaya Therapeutics (NASDAQ: TNYA) was provided by Chardan Capital, and Tenaya Therapeutics reiterated their buy rating.
When was the last upgrade for Tenaya Therapeutics (TNYA)?
There is no last upgrade for Tenaya Therapeutics.
When was the last downgrade for Tenaya Therapeutics (TNYA)?
There is no last downgrade for Tenaya Therapeutics.
When is the next analyst rating going to be posted or updated for Tenaya Therapeutics (TNYA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenaya Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenaya Therapeutics was filed on March 21, 2024 so you should expect the next rating to be made available sometime around March 21, 2025.
Is the Analyst Rating Tenaya Therapeutics (TNYA) correct?
While ratings are subjective and will change, the latest Tenaya Therapeutics (TNYA) rating was a reiterated with a price target of $0.00 to $20.00. The current price Tenaya Therapeutics (TNYA) is trading at is $4.75, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.